“Formulation and optimization of liquisolid tablet for improving the dissolution profile of rivaroxaban by using DoE approachand antithrombic activity” (2025) Journal of Carcinogenesis, 24(3s), pp. 812–830. doi:10.64149/J.Carcinog.24.3s.812-830.